Ascendis Pharma
DenmarkEntry
2012
Hold
3yr
Exit
2015
Who owns Ascendis Pharma?
Ascendis Pharma was owned by Sofinnova Partners through Sofinnova Capital VII (2012 vintage) from 2012 to 2015, exited via IPO. Across its history, Ascendis Pharma has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Sofinnova PartnersSofinnova Capital VII · 2012 · Life Sciences VC
2 ownership periods · full history below
Key facts
HQDenmark
SectorHealthcare / Biotech
Key takeaways
- ·Fully exited in 2015.
- ·Average hold across 2 realized cycles: 4 years.
Ownership history
2 ownership periods · co-invest detected
Exited
Last exited in 2015.
Co-invest · 2 holders · 2010 · 2015
Sunstone Life Science VenturesExited 2015
2010 · 2015(5yr) · Sunstone Life Science Ventures III · 2007 · VC
IPO
MOIC
–
More from Sofinnova Capital VII
Other portfolio companies in the same fund.
France
Italy
SwitzerlandMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Ascendis Pharma
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Ascendis Pharma?
1 strategic and 119financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Ascendis Pharma.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue